Literature DB >> 11325342

Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease.

C K Abrams1, M M Freidin, V K Verselis, M V Bennett, T A Bargiello.   

Abstract

CMTX, the X-linked form of Charcot-Marie-Tooth disease, is an inherited peripheral neuropathy arising in patients with mutations in the gene encoding the gap junction protein connexin 32 (Cx32). In this communication, we describe the expression levels and biophysical parameters of seven mutant forms of Cx32 associated with CMTX, when expressed in paired Xenopus oocytes. Paired oocytes expressing the R15Q and H94Q mutants show junctional conductances not statistically different from that determined for Cx32WT, though both show a trend toward reduced levels. The S85C and G12S mutants induce reduced levels of junctional conductance. Three other mutants (R15W, H94Y and V139M) induce no conductance above baseline when expressed in paired oocytes. Analysis of the conductance voltage relations for these mutants shows that the reduced levels of conductance are entirely (H94Y and V139M) or partly (S85C and R15W) explicable by a reduced open probability of the mutant hemichannels. The R15Q and H94Q mutations also show alterations in the conductance voltage relations that would be expected to minimally (H94Q) or moderately (R15Q) reduce the available gap junction communication pathway. The reduction in G12S induced conductance cannot be explained by alterations in hemichannel open probability and are more likely due to reduced junction formation. These results demonstrate that many CMTX mutations lead to loss of function of Cx32. For these mutations, the loss of function model is likely to explain the pathogenesis of CMTX.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325342      PMCID: PMC4517190          DOI: 10.1016/s0006-8993(00)03327-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  52 in total

1.  Molecular analysis of voltage dependence of heterotypic gap junctions formed by connexins 26 and 32.

Authors:  J B Rubin; V K Verselis; M V Bennett; T A Bargiello
Journal:  Biophys J       Date:  1992-04       Impact factor: 4.033

2.  A domain substitution procedure and its use to analyze voltage dependence of homotypic gap junctions formed by connexins 26 and 32.

Authors:  J B Rubin; V K Verselis; M V Bennett; T A Bargiello
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  Voltage gating and permeation in a gap junction hemichannel.

Authors:  E B Trexler; M V Bennett; T A Bargiello; V K Verselis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Connexin 32 of gap junctions contains two cytoplasmic calmodulin-binding domains.

Authors:  K Török; K Stauffer; W H Evans
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

5.  X-linked dominant Charcot-Marie-Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations(1).

Authors:  J Senderek; B Hermanns; C Bergmann; B Boroojerdi; M Bajbouj; M Hungs; V T Ramaekers; S Quasthoff; D Karch; J M Schröder
Journal:  J Neurol Sci       Date:  1999-08-15       Impact factor: 3.181

6.  Isoform composition of connexin channels determines selectivity among second messengers and uncharged molecules.

Authors:  C G Bevans; M Kordel; S K Rhee; A L Harris
Journal:  J Biol Chem       Date:  1998-01-30       Impact factor: 5.157

7.  Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects.

Authors:  Y Omori; M Mesnil; H Yamasaki
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

Review 8.  Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies.

Authors:  E Nelis; N Haites; C Van Broeckhoven
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

9.  Genotype/phenotype correlation in affected individuals of a family with a deletion of the entire coding sequence of the connexin 32 gene.

Authors:  P J Ainsworth; C F Bolton; B C Murphy; J A Stuart; A F Hahn
Journal:  Hum Genet       Date:  1998-08       Impact factor: 4.132

10.  Sex-linked recessive inheritance in Charcot-Marie-tooth disease with partial clinical manifestations in female carriers.

Authors:  J P Fryns; H Van den Berghe
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

View more
  29 in total

1.  The role of gap junctions in Charcot-Marie-Tooth disease.

Authors:  Kleopas A Kleopa
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

2.  Four novel connexin 32 mutations in X-linked Charcot-Marie-Tooth disease with phenotypic variability.

Authors:  G Karadima; M Panas; P Floroskufi; N Kalfakis; D Vassilopoulos
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

Review 3.  Gap junctions in inherited human disease.

Authors:  Georg Zoidl; Rolf Dermietzel
Journal:  Pflugers Arch       Date:  2010-02-07       Impact factor: 3.657

Review 4.  Gap junctions in inherited human disorders of the central nervous system.

Authors:  Charles K Abrams; Steven S Scherer
Journal:  Biochim Biophys Acta       Date:  2011-08-16

Review 5.  Structural organization of intercellular channels II. Amino terminal domain of the connexins: sequence, functional roles, and structure.

Authors:  Eric C Beyer; Gregory M Lipkind; John W Kyle; Viviana M Berthoud
Journal:  Biochim Biophys Acta       Date:  2011-10-20

Review 6.  Molecular genetics of X-linked Charcot-Marie-Tooth disease.

Authors:  Kleopas A Kleopa; Steven S Scherer
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

7.  Post-translational modifications of connexin26 revealed by mass spectrometry.

Authors:  Darren Locke; Shengjie Bian; Hong Li; Andrew L Harris
Journal:  Biochem J       Date:  2009-12-10       Impact factor: 3.857

8.  Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations.

Authors:  Jennifer L Orthmann-Murphy; Ettore Salsano; Charles K Abrams; Alberto Bizzi; Graziella Uziel; Mona M Freidin; Eleonora Lamantea; Massimo Zeviani; Steven S Scherer; Davide Pareyson
Journal:  Brain       Date:  2008-12-04       Impact factor: 13.501

9.  Functional requirement for a highly conserved charged residue at position 75 in the gap junction protein connexin 32.

Authors:  Charles K Abrams; Mahee Islam; Rola Mahmoud; Taekyung Kwon; Thaddeus A Bargiello; Mona M Freidin
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

10.  A new mutation in GJC2 associated with subclinical leukodystrophy.

Authors:  Charles K Abrams; Steven S Scherer; Rafael Flores-Obando; Mona M Freidin; Sarah Wong; Eleonora Lamantea; Laura Farina; Vidmer Scaioli; Davide Pareyson; Ettore Salsano
Journal:  J Neurol       Date:  2014-07-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.